Noradrenergic Mechanisms in Parkinson's Disease

1. Auflage 1993
ISBN: 978-0-8493-8391-5
Verlag: CRC Press

Buch, Englisch, 288 Seiten, Format (B × H): 156 mm x 235 mm, Gewicht: 703 g

Noradrenergic Mechanisms in Parkinson's Disease examines fundamental and clinical evidence explaining the progression of the disease. Featuring contributions from acknowledged international experts in the field, this book defines ideopathic Parkinson's disease and covers such topics as the alterations in Parkinson's disease, norepinephrine-dopamine interactions, noradrenergic control of striatal dopamine release, glial cells as targets of the central noradrenergic systems, and a theory regarding noradrenergic mechanisms in Parkinson's disease. New directions for research on Parkinson's disease are also explored.

Zielgruppe

Neuroscientists, psychopharmacologists, and neurochemists.

Autoren/Hrsg.

Briley, Mike

Marien, M.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Endokrinologie

Inhaltsverzeichnis

PrefaceThe ContributorsDefining Ideopathic Parkinson's Disease, J.M. GyblesThe Validity of the MPTP Primate Model for the Neurochemical Pathology of Idiopathic Parkinson's Disease, O. Hornykiewicz and C. PiflRecovery from MPTP-Induced Parkinsonian Manifestations Following Locus Coereleus Lesions in Squirrel Monkeys, M. MavridisThe Possible Role of Noradrenergic Deficits in Selected Signs of Parkinson's Disease, M. Gerlach, K. Jellinger, and P. RiedererAnatomy of the Noradrenergic Pathways in the Primate Brain: Alterations in Parkinson's Disease, P. GasparThe Locus Coeruleus in Parkinson's Disease, R. Raisman-VozariInteractions between Noradrenaline and Dopamine Neurotransmission in the Rat Prefrontal Cortex and Their Consequences on Dopaminergic Subcortical Function, J.P. Tassin, F. Trovero, G. Blanc, D. Hervé, and J. GlowinskiNorepinephrine-Dopamine Interactions: One Step Beyond, S.M. Antelman and A.R. CaggiulaNoradrenergic Control of Striatal Dopamine Release, M. Marien, A. Lategan, and F. ColpaertThe Effects of a2 Adrenoceptor Antagonists on Extracellular Dopamine Concentrations in Rat Striatum, D. Nutt, M. Lalies, and A. HudsonGlial Cells as Targets of the Central Noradrenergic System-An Update., E.A. StoneAdrenergic Activation of Phospholipase C in Striatal Astrocytes: Neurotransmitter Interactions, M. El-EtrNoradrenergic Control of Gap Junction Permeability in Cultured Striatal Astrocytes, C. GiaumeNoradrenergic Mechanisms in Parkinson's Disease: A Theory, F.C. Colpaert